𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour

✍ Scribed by Karen A. Herd; Tracey Harvey; Alexander A. Khromykh; Robert W. Tindle


Book ID
113945779
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
390 KB
Volume
319
Category
Article
ISSN
0042-6822

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Oral immunization with a Lactobacillus c
✍ Katsuyuki Adachi; Kei Kawana; Terufumi Yokoyama; Tomoyuki Fujii; Ayako Tomio; Sh πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 528 KB

Although many clinical trials on human papillomavirus (HPV) therapeutic vaccines have been performed, clinical responses have not been consistent. We have addressed mucosal cytotoxic cellular immune responses to HPV16 E7 after oral immunization of mice with recombinant Lactobacillus casei expressing

Immune response to human papillomavirus
✍ Klaus SchΓ€fer; Martin MΓΌller; Stefan Faath; Annette Henn; Wolfram Osen; Hanswalt πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 146 KB πŸ‘ 1 views

Expression of human papillomavirus type 16 (HPV 16) fusion proteins LI deltaCE7(1-55) and LI deltaCE7(1-60) (carboxy-terminal deletion of LI replaced by 55 or 60 amino-terminal amino acids of E7) leads to formation of chimeric papillomavirus-like particles (CVLPs). After "infection" of cells by CVLP